News
GCRFF
0.320
NaN%
--
GoldCoast Resource Maps 22 Offshore Gold Targets Off Ghana’s Coast
TipRanks · 10/27 23:41
Airborne Magnetic Survey Generates 22 Priority Gold Exploration Targets
Newsfile · 10/27 21:15
GoldCoast Resource Secures Government Clarification on Ghana Offshore Licences
TipRanks · 10/19 20:07
GoldCoast Resource Corp. Confirms Government of Ghana to Issue Public Statement Clarifying GoldCoast's Licenses Have Not Been Suspended
Newsfile · 10/19 19:43
GoldCoast Resource Corp. Halts Trading Pending Ghana Licence Clarification
TipRanks · 10/14 18:38
GoldCoast Resource Corp. Announces Trading Halt Pending Clarification from Government of Ghana
Newsfile · 10/14 17:24
GoldCoast insists Ghana offshore licenses intact as operations pause for stakeholder review
TipRanks · 10/08 17:33
GoldCoast Resource Corp. Clarifies Media Reports and Confirms Offshore Licenses Remain in Good Standing
Newsfile · 10/08 16:28
GoldCoast Resource Corp. Lists on OTCQB to Support Offshore Ghana Gold Strategy
TipRanks · 09/30 18:02
GoldCoast Resource ramps up offshore Ghana gold exploration after CSE debut
TipRanks · 08/18 18:51
Psyence Group Announces Name Change, Share Consolidation and Closing of RTO with GoldCoast Resource Corp.
Barchart · 07/28 10:25
Psyence Partner GoldCoast Raises $8.6 Million, Clearing Key Merger Hurdle
TipRanks · 03/24 23:39
Psyence Advances GoldCoast Reverse Takeover as Partner Raises $5.8 Million
TipRanks · 03/20 14:37
Psyence Extends GoldCoast Amalgamation Timeline and Lowers Cash Condition
TipRanks · 02/24 16:40
Psyence RTO Target GoldCoast Wins Major Offshore Gold Reconnaissance Licences in Ghana
TipRanks · 01/27 16:34
Psyence Group says GoldCoast Resource granted offshore reconnaissance license
TipRanks · 01/27 14:55
More
Webull provides a variety of real-time GCRFF stock news. You can receive the latest news about Goldcoast Resource Corp through multiple platforms. This information may help you make smarter investment decisions.
About GCRFF
GoldCoast Resource Corp. is a Canada-based life science biotechnology company with a focus on natural psychedelics. The Company is focused on the research, cultivation and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness. It cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at its federally licensed ISO22000 facility in Southern Africa. The Company’s divisions include Psyence Production, Psyence Therapeutics and Psyence Function. Psyence Therapeutics develops natural psilocybin products, medicinal formulations and treatment protocols to treat mental health disorders in a clinical environment. Psyence Production operates federally licensed ISO22000-certified psilocybin cultivation and production facilities in the world. Psyence Function is focused on the development, distribution and sale of over-the-counter functional mushroom nutraceutical products.